Spectrum Wealth Counsel’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Spectrum Wealth Counsel’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-82	Closed	-$1.9K	–	405
2024 Q2	$1.9K	Hold	82	–	–	﹤0.01%	346
2024 Q1	$1.98K	Hold	82	–	–	﹤0.01%	346
2023 Q4	$1.89K	Buy	+82	New	+$1.65K	﹤0.01%	309

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

CCA

Cora Capital Advisors Marlton, New Jersey $302M AUM 16.46% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Spectrum Wealth Counsel's IDNA Position: Q3 2024 in Review

Spectrum Wealth Counsel sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2024, closing a stake of 82 shares — an estimated $1.9K sold.

Spectrum Wealth Counsel first reported a position in IDNA in Q4 2023 and held it in 3 quarters. The position peaked at $1.98K in Q1 2024. 53 funds tracked by Wall St. Rank hold IDNA as of Q3 2024.

Spectrum Wealth Counsel reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2024 after selling out during the quarter.
Spectrum Wealth Counsel sold 82 iShares Genomics Immunology and Healthcare ETF shares in Q3 2024, an estimated $1.9K.
Spectrum Wealth Counsel first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2023 and held it in 3 quarters.
Spectrum Wealth Counsel's iShares Genomics Immunology and Healthcare ETF position peaked at $1.98K in Q1 2024.
53 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2024.

Based on Spectrum Wealth Counsel's 13F filing for Q3 2024, filed 8 Nov 2024.